IPC - 2018 Events

2018 Events

TREATING TO GOAL: CLEAR PATH TO PATIENT-CENTERED PSORIASIS MANAGEMENT

76th Annual Meeting of the American Academy of Dermatology (AAD) | San Diego, California, USA

Thursday, February 15, 2018 | 3:00 - 4:30 pm
San Diego Convention Center, Room 29AB

Program Faculty: Chris Griffiths, Paolo Gisondi, Peter van de Kerkhof

IPC MASTERS COURSE | MUMBAI, INDIA

Saturday, March 24 | 9:00 am – 6:00 pm
Sunday, March 25 | 9:00 am – 3:00 pm
Novotel hotel

Program Chair: Murlidhar Rajagopalan
Program Faculty: Alan Menter, Lars Iversen, Sushil Tahiliani

WHAT'S NEW IN PSORIASIS: AN UPDATE BY THE INTERNATIONAL PSORIASIS COUNCIL

36th Reunión Anual de Dermatólogos Latinoamericanos (RADLA) | Cancun, Mexico

Saturday, April 28, 2018 | 8:30 - 10:30 am
Grand Fiesta Americana

Program Chairs: Claudia de la Cruz & Ricardo Romiti
Program Faculty: Matthias Augustin, André Vicente Esteves de Carvalho, Matías Maskin, Fernando Valenzuela

Psoriatic Disease Mechanistic Scenarios

7th International Investigative Dermatology Meeting (IID) | Orlando, Florida, USA

Wednesday, May 16, 2018 | 1:00 - 4:30 pm
Rosen Shingle Creek Resort, Room St. John’s 28 & 29 – Level 2

Program Chairs: Hervé Bachelez & Johann Gudjonsson
Program Faculty: Jonathan Barker, Nicole Ward, Kazumitsu Sugiura
Poster Presentations: Zeyu Chen, Helen Hermann, Mark Mellett, Sara Brown, Marilyn Wan, Zhu Shen, Shuai Shao

PERSONALIZED PSORIASIS TREATMENT: REAL WORLD PRACTICE APPROACHES AND KEY GLOBAL INSIGHTS27th Congress of the European Academy of Dermatology and Venereology (EADV) | Paris, France

Wednesday, September 12, 2018 | 10:00 am - 1:00 pm
Palais des Congrès de Paris, Room 242AB

Program Chair: Peter van de Kerkhof
Program Faculty: Murlidhar Rajagopalan, Peter van de Kerkhof, & Claus Zachariae

HOT TOPICS IN PSORIASIS: AN UPDATE BY THE INTERNATIONAL PSORIASIS COUNCIL

Congreso Ibero Latinoamericano de Dermatología (CILAD) | São Paulo, Brazil

Friday, November 16 | 12:30 - 2:00 pm

Program Chairs: Matías Maskin & Ricardo Romiti
Program Faculty: Claudia de la Cruz, Carle Paul, César Gonzalez, & Fernando Valenzuela

Return to 2019 events

congress coverage

EADV 2019

Read the psoriasis highlights from the EADV 2019 congress

learn more

Latest news

Commentary: Dermatologists and SARS - CoV - 2: the impact of the pandemic on daily practice

July 22, 2020

Paolo Gisondi et al., summarize issues faced by many dermatologists during the unprecedented lockdown period in Spring 2020 due to the COVID-19 pandemic. Issues like the sudden cancellation of face-to-face consultations, and the mandatory introduction of telemedicine (after months of a rather optional exercise with this type of caregiving), needed an entrepreneurial approach to manage.

Lilly's Mirikizumab Superior to Cosentyx® (secukinumab) in a Phase 3 Study for Patients with Moderate to Severe Plaque Psoriasis

July 20, 2020

Eli Lilly and Company (NYSE:LLY) announced today that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the primary and all key secondary endpoints versus placebo at Week 16 (superiority) and all key secondary endpoints versus Cosentyx (secukinumab) at Week 16 (non-inferiority) and Week 52 (superiority) in the OASIS-2 study. OASIS-2 is a multicenter randomized, double-blind, placebo-controlled study comparing the efficacy and safety of mirikizumab to placebo and Cosentyx in patients with moderate to severe plaque psoriasis.

Pathogenesis of Psoriasis

July 14, 2020

Dr. Stingl discusses differences in the pathogenesis of plaque psoriasis and pustular psoriasis. Spoiler alert: it's the neutrophils.

PsoProtectMe now available in multiple languages

July 09, 2020